Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today

Data from Stocktwits shows that retail positioning has remained ‘bullish’ for SPY and QQQ amid geopolitical instability.
US stocks illustration.
US stocks illustration. Image via Vecteezy
Profile Image
Preeti Ayyathurai·Stocktwits
Updated Apr 20, 2026   |   4:28 AM EDT
Share
·
Add us onAdd us on Google
  • U.S. stock futures pulled back early Monday, cooling off after last week’s record-setting gains.
  • Investors are monitoring a renewed flare-up in the Strait of Hormuz, after Iran signaled the critical shipping route would remain restricted amid an ongoing standoff with the U.S.
  • Psychedelic stocks catch a policy tailwind around expedited drug approvals for mental health treatment: PBM, DFTX, and CMPS are seeing retail attention. 

U.S. stock futures were under pressure early Monday, after reaching record highs last week amid easing geopolitical fears in the Middle East. However, tensions are on the rise again after President Donald Trump confirmed the seizure of an Iranian-flagged cargo ship in the Strait of Hormuz, prompting Iran to re-close the vital waterway.

Trump threatened to "knock out every power plant" in Iran if a new deal is not reached during upcoming talks in Islamabad this week. Oil-linked stocks such as BATL and EONR are back on the radar following a spike in crude volatility.

As of 4:00 a.m. ET on Monday, S&P 500 and Nasdaq futures fell 0.6%, Dow futures slipped 0.7%, and Russell 2000 futures were down 1%. 

Retail sentiment toward the SPDR S&P 500 ETF (SPY), an exchange-traded fund that tracks the S&P 500 Index, and the Invesco QQQ Trust (QQQ) ETF, which tracks the Nasdaq-100 Index, remained ‘extremely bullish.’

Trending Stocks To Watch

Psyence Biomedical (PBM): Retail is piling into this little-known psychedelic supplier following U.S. President Donald Trump’s executive order over the weekend to expedite the review of psychedelic medicines, including ibogaine and psilocybin for PTSD and addiction treatment. Also watch out for Definium Therapeutics (DFTX) and Compass Pathways (CMPS). 

Marvell (MRVL): Reports suggest that Google is in talks with the firm to design two new AI chips, including a next-generation TPU. 

AST SpaceMobile (ASTS): The stock fell 14% in early pre-market trading after the company confirmed that its BlueBird-7 satellite, launched on New Glenn 3, was placed in an orbit too low to sustain operations. 

Fermi LLC (FRMI): The stock cracked 16% in early pre-market trade on Monday following a massive leadership overhaul. Early this morning, Fermi announced a transition from its "start-up" roots to a "scaled enterprise.”

Critical Metals Corp. (CRML): Remains on retail radar following the updates for its Tabrez project. Meanwhile, on Sunday, Chairman Tony Sage said in a social media post that, while the geopolitical situation has made shipping logistics "tricky," the company still targets Q2 2026 for operations at its Greenland pilot plant.

Eli Lilly (LLY): Reports suggest that the company is in advanced talks to acquire Kelonia Therapeutics for over $2B, a deal that could be announced as early as today.

Tesla, Inc (TSLA): The stock is on track for its first positive month this year, ahead of its earnings report this week. Meanwhile, Elon Musk downplayed competitive fears from China’s BYD, framing execution and not competition as the EV maker’s key challenge.

Other tickers trending on Stocktwits at the time of writing included AEVEX Corp (AVEX), Blackberry (BB), and Nvidia Corp (NVDA). 

Other Catalysts To Watch

On the economic front, no notable data release is expected.

On earnings radar, watch out for quarterly reports from Cleveland-Cliffs Inc (CLF), Nano X Imaging Ltd (NNOX), and Dynex Capital Reit Inc (DX) before the bell. Also, Lion Group Holding Ltd (LGHL), AGNC Investment Corp (AGNC), Lottery.com Inc (SEGG), and Alaska Air Group Inc (ALK) report after market close on Monday.

For updates and corrections, email newsroom[at]stocktwits[dot]com

Follow on Google News
Read about our editorial guidelines and ethics policy